Shyam Srinivasan
Stock Analyst at Goldman Sachs
(0.25)
# 4,572
Out of 5,055 analysts
83
Total ratings
44.2%
Success rate
-12.6%
Average return
Main Sectors:
Stocks Rated by Shyam Srinivasan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: DIVISLAB Divi's Laboratories Limited | Upgraded: Buy | ₹6,375 → ₹8,035 | ₹9,023 | -10.95% | 6 | May 29, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Downgraded: Sell | ₹1,200 → ₹1,075 | ₹1,216 | -11.60% | 6 | Apr 23, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Reiterated: Buy | ₹7,850 → ₹8,550 | ₹7,824 | +9.28% | 2 | Dec 7, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Downgraded: Hold | ₹700.00 → ₹965.00 | ₹750.00 | +28.67% | 2 | Dec 7, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Initiated Coverage: Buy | ₹900.00 | ₹691.55 | +30.14% | 1 | Dec 7, 2025 | |
| NSE: MAXHEALTH Max Healthcare Institute Limited | Initiated Coverage: Buy | ₹1,325 | ₹852.50 | +55.43% | 1 | Dec 7, 2025 | |
| NSE: ICICIPRULI ICICI Life Insurance Limited | Reiterated: Hold | ₹625.00 → ₹650.00 | ₹445.00 | n/a | 3 | Oct 15, 2025 | |
| NSE: LAURUSLABS Laurus Labs Limited | Reiterated: Sell | ₹675.00 → ₹750.00 | ₹2,037 | n/a | 8 | Oct 14, 2025 | |
| NSE: NEULANDLAB Neuland Laboratories Limited | Reiterated: Buy | ₹15,750 → ₹17,225 | ₹20,200 | n/a | 5 | Oct 14, 2025 | |
| NSE: BIOCON Biocon Limited | Reiterated: Hold | ₹345.00 → ₹335.00 | ₹350.60 | n/a | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹800.00 → ₹775.00 | ₹390.75 | n/a | 5 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,300 → ₹1,250 | ₹1,663 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,375 → ₹1,350 | ₹1,315 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,435 → ₹1,525 | ₹3,049 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,975 | ₹1,953 | n/a | 4 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹265.00 → ₹250.00 | ₹194.08 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹830.00 → ₹890.00 | ₹544.05 | n/a | 2 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹465.00 | ₹394.00 | n/a | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,860 → ₹2,015 | ₹1,650 | n/a | 3 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,650 → ₹1,680 | ₹1,722 | n/a | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,325 | ₹1,932 | n/a | 1 | Apr 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,475 → ₹1,500 | ₹1,746 | n/a | 4 | Apr 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,350 | ₹447.70 | n/a | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,675 | ₹522.90 | n/a | 1 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,975 | ₹1,713 | n/a | 1 | Jan 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.825 | n/a | 1 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $12.75 | n/a | 1 | May 2, 2016 |
Divi's Laboratories Limited
May 29, 2026
Upgraded: Buy
Price Target: ₹6,375 → ₹8,035
Current: ₹9,023
Upside: -10.95%
Dr. Reddy's Laboratories Limited
Apr 23, 2026
Downgraded: Sell
Price Target: ₹1,200 → ₹1,075
Current: ₹1,216
Upside: -11.60%
Apollo Hospitals Enterprise Limited
Dec 7, 2025
Reiterated: Buy
Price Target: ₹7,850 → ₹8,550
Current: ₹7,824
Upside: +9.28%
Fortis Healthcare Limited
Dec 7, 2025
Downgraded: Hold
Price Target: ₹700.00 → ₹965.00
Current: ₹750.00
Upside: +28.67%
Krishna Institute of Medical Sciences Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹900.00
Current: ₹691.55
Upside: +30.14%
Max Healthcare Institute Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹1,325
Current: ₹852.50
Upside: +55.43%
ICICI Life Insurance Limited
Oct 15, 2025
Reiterated: Hold
Price Target: ₹625.00 → ₹650.00
Current: ₹445.00
Upside: n/a
Laurus Labs Limited
Oct 14, 2025
Reiterated: Sell
Price Target: ₹675.00 → ₹750.00
Current: ₹2,037
Upside: n/a
Neuland Laboratories Limited
Oct 14, 2025
Reiterated: Buy
Price Target: ₹15,750 → ₹17,225
Current: ₹20,200
Upside: n/a
Biocon Limited
Aug 8, 2025
Reiterated: Hold
Price Target: ₹345.00 → ₹335.00
Current: ₹350.60
Upside: n/a
Jul 24, 2025
Reiterated: Buy
Price Target: ₹800.00 → ₹775.00
Current: ₹390.75
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: ₹1,300 → ₹1,250
Current: ₹1,663
Upside: n/a
Jul 15, 2025
Reiterated: Sell
Price Target: ₹1,375 → ₹1,350
Current: ₹1,315
Upside: n/a
Jul 15, 2025
Reiterated: Sell
Price Target: ₹1,435 → ₹1,525
Current: ₹3,049
Upside: n/a
Jul 15, 2025
Reiterated: Hold
Price Target: ₹1,975
Current: ₹1,953
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: ₹265.00 → ₹250.00
Current: ₹194.08
Upside: n/a
Jul 8, 2025
Reiterated: Buy
Price Target: ₹830.00 → ₹890.00
Current: ₹544.05
Upside: n/a
Jul 8, 2025
Reiterated: Hold
Price Target: ₹465.00
Current: ₹394.00
Upside: n/a
Jul 8, 2025
Reiterated: Buy
Price Target: ₹1,860 → ₹2,015
Current: ₹1,650
Upside: n/a
May 2, 2025
Reiterated: Sell
Price Target: ₹1,650 → ₹1,680
Current: ₹1,722
Upside: n/a
Apr 26, 2025
Reiterated: Sell
Price Target: ₹1,325
Current: ₹1,932
Upside: n/a
Apr 18, 2025
Reiterated: Sell
Price Target: ₹1,475 → ₹1,500
Current: ₹1,746
Upside: n/a
Apr 8, 2025
Initiated Coverage: Buy
Price Target: ₹1,350
Current: ₹447.70
Upside: n/a
Feb 6, 2025
Reiterated: Sell
Price Target: ₹1,675
Current: ₹522.90
Upside: n/a
Jan 19, 2025
Reiterated: Hold
Price Target: ₹1,975
Current: ₹1,713
Upside: n/a
Jul 26, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.825
Upside: n/a
May 2, 2016
Initiated Coverage: Hold
Price Target: n/a
Current: $12.75
Upside: n/a